<DOC>
	<DOCNO>NCT01465035</DOCNO>
	<brief_summary>This single blind placebo control phase I study , assess safety immunogenicity co-administration candidate influenza vaccine MVA-NP+M1 seasonal influenza vaccine . All volunteer recruit adult age 50 . The rationale behind co-administration MVA-NP+M1 seasonal influenza vaccine ( TIV ) immune system stimulate produce influenza specific T cell influenza specific antibody .</brief_summary>
	<brief_title>A Study Determine Safety Immunogenicity Co-administration Candidate Influenza Vaccine MVA-NP+M1 Seasonal Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Men woman age 50 upper age limit Resident near Oxford duration vaccination study Able willing ( Investigators ' opinion ) comply study requirement Willing allow investigator discuss volunteer 's medical history General Practitioner For female postmenopausal , negative pregnancy test day vaccination agreement practice effective contraception duration study Agreement refrain blood donation course study Written inform consent Participation another research study involve investigational product 30 day precede enrolment , plan use study period Receipt MVA smallpox vaccine last 5 year , receipt 2011/12 seasonal influenza vaccine prior enter study . Administration immunoglobulins and/or blood product within three month precede plan administration vaccine candidate Any confirm suspected immunosuppressive immunodeficient state , include HIV infection ; asplenia ; recurrent , severe infection chronic ( 14 day ) immunosuppressant medication within past 6 month ( inhaled/topical steroid allow ) History allergic disease reaction likely exacerbate component vaccine , e.g . egg product Any history anaphylaxis reaction vaccination Recent treatment cancer ( except basal cell carcinoma cervical carcinoma situ ) History serious psychiatric condition Suspected known current inject drug alcohol abuse ( define alcohol intake great 42 unit every week ) Seropositive hepatitis B surface ( HBsAg ) hepatitis C virus ( antibody HCV ) For premenopausal female , pregnancy , lactation willingness/intention become pregnant study Any significant disease , disorder finding ( include blood test result ) , , opinion Investigators , would either put volunteer risk participation study , may influence result study . No response / confirmation GP regard previous medical history</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>